Fineotex acquires 53.33% stake in US specialty oilfield chemicals group

Listed-company acquisitionStrategic Transactions View source PDF Explain this filing

FCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.9%Reaction day

₹24.04

prior close

₹25.37

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.1%+7.0% vs market

Specialty Chemicals peers, median of 88sector-0.3%+6.2% vs sector

On the reaction day the stock moved 7.0 pts more than Nifty Microcap 250 and 6.2 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.0

15m

+0.0

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.9-1.1+7.0-0.3+6.2

Next day

+3.6-3.5+7.0-2.4+6.0

+4.8-1.6+6.3-1.6+6.4

+1.5-2.2+3.7-1.9+3.4

+1.9-1.8+3.7-1.1+3.0

+1.7-1.5+3.1-0.7+2.4

+1.1-1.6+2.7-0.7+1.8

15d

+4.8-2.0+6.8-1.5+6.3

+1.4+0.7+0.7-1.8+3.2

-3.2-3.8+0.6-5.2+2.0

-7.4-9.8+2.4-13.6+6.3

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 88Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Fineotex Chemical, via subsidiary Fineotex Biotex Healthguard FZE, will acquire 53.33% stake in 4 US firms (CrudeChem Technology, FrackMex Equipment, Oil Pro Advantage, Lonestar Technoboost) for about USD 11.2 million in cash. Targets serve the oil and gas industry. Deal to close within 1 month. FCL aims to build a 200 million dollar oilfield chemicals business.

Likely market impact

Entry into US oilfield chemicals market worth 11.5 billion dollars. Supports FCLs plan to build a 200 million dollar oilfield business.